Improving Outcomes in Bipolar Disorder Through Community Pharmacist Interventions
This activity is supported by an educational grant from Sunovion Pharmaceuticals, Inc.
Improving Outcomes in Bipolar Disorder Through Community Pharmacist Interventions
Faculty
Megan Maroney, PharmD, BCPP
Clinical Assistant Professor
Department of Pharmacy Practice and Administration
Ernest Mario School of Pharmacy
Rutgers, the State University of New Jersey
Clinical Psychiatric Pharmacist
Monmouth Medical Center
Long Branch, New Jersey
Activity Overview
Bipolar disorder affects approximately 60 million people worldwide and ranks as the 12th leading cause of disability globally. This continuing education activity is designed to discuss the features and impact of bipolar disorder, summarize the treatment landscape and pipeline activity for the disease, and describe effective counseling strategies that pharmacists can employ.
Educational Objectives:
After completing this continuing education program, the participant will be able to:
- Discuss the disabling features of bipolar disorder and its significant impact on patients and society.
- Summarize the expansive treatment landscape for bipolar disorder and the role of emerging agents.
- Describe effective counseling strategies that pharmacists can employ for patients with bipolar disorder.
Target audience:
Pharmacists
Type of activity:
Knowledge
Release date:
March 6, 2015
Expiration date:
March 6, 2017
Estimated time to complete activity:
2.0 hours
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-15-012-H01-P. The activity is available for CE credit through March 6, 2017.
Articles in this issue
over 10 years ago
Article
The Pharmacist's Role in Improving the Clinical Outcomes of Patients with SchizophreniaNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025